Acasti Pharma Inc ACST:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:22 PM EDT
0.58quote price arrow down-0.00 (-0.60%)
Volume
696
Close
0.5835quote price arrow up+0.0222 (+3.96%)
Volume
46,123
52 week range
0.55 - 2.04
Loading...
  • Open0.5936
  • Day High0.6008
  • Day Low0.5802
  • Prev Close0.5613
  • 52 Week High2.04
  • 52 Week High Date10/01/21
  • 52 Week Low0.55
  • 52 Week Low Date09/29/22

Key Stats

  • Market Cap26.91M
  • Shares Out44.49M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-53.69

KEY STATS

  • Open0.5936
  • Day High0.6008
  • Day Low0.5802
  • Prev Close0.5613
  • 52 Week High2.04
  • 52 Week High Date10/01/21
  • 52 Week Low0.55
  • 52 Week Low Date09/29/22
  • Market Cap26.91M
  • Shares Out44.49M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-53.69

RATIOS/PROFITABILITY

  • EPS (TTM)-0.26
  • P/E (TTM)-2.22
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date11/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Acasti Pharma Inc

 

Profile

MORE
Acasti Pharma Inc. is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: Subarachnoid Hemorrhage (SAH), Ataxia Telangiectasia (A-T), and Postherpetic Neuralgia (PHN). The Company's lead product candidate includes GTX-104, which is a clinical-stage nanoparticle formulation of nimodipine being developed for IV infusion in SAH patients. The Company's...
Roderick Carter
Independent Chairman of the Board
Janelle D'Alvise
President, Chief Executive Officer, Director
Pierre Lemieux Ph.D.
Chief Operating Officer, Chief Scientific Officer
Brian Ford CPA
Chief Financial Officer
Address
102-3009 boul. de la Concorde E
Laval, QC
H7E 2B5
Canada